Form D — Immunovant, Inc.
0001231919-25-000012 · filed Jan 21, 2025
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $450,000,000
- Total sold
- $450,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Immunovant, Inc.
- CIK
- 1764013
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 320 WEST 37TH STREET
NEW YORK, NY 10018 - Phone
- 917-580-3099
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Pete Salzmann · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Eva Renee Barnett · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Michael Geffner · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Melanie Gloria · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Bill Macias · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Jay Stout · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Christopher Van Tuyl · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Frank Torti · DirectorNew York, NY Find on LinkedIn ↗
-
Andrew Fromkin · DirectorNew York, NY Find on LinkedIn ↗
-
Douglas Hughes · DirectorNew York, NY Find on LinkedIn ↗
-
George Migausky · DirectorNew York, NY Find on LinkedIn ↗
-
Atul Pande · DirectorNew York, NY Find on LinkedIn ↗
-
Eric Venker · DirectorNew York, NY Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗